Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium
References (82)
- et al.
A genetic model for colorectal tumorigenesis
Cell
(1990) - et al.
Lessons from hereditary colorectal cancer
Cell
(1996) - et al.
p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis
Hum Pathol
(1995) - et al.
Molecular pathology of endometrial hyperplasia and carcinoma
Hum Pathol
(2001) - et al.
Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression
Hum Pathol
(1998) - et al.
Peripheral aromatization as a risk factor for breast and endometrial cancer in postmenopausal women: a review
Gynecol Oncol
(1984) Theories of endometrial carcinogenesis: a multidisciplinary approach
Mod Pathol
(2000)- et al.
Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation
Hum Pathol
(1995) - et al.
The outcome of stage III clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma
Gynecol Oncol
(2000) Pten, a protean tumor suppressor
Am J Pathol
(2001)
hMLH1 promoter hypermethylation is an early event in human endometrial tumorigen- esis
Am J Pathol
(1999)
The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer
Am J Med
(1994)
Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium
Hum Pathol
(1998)
E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium
Obstet Gynecol
(2002)
Molecular characterization of uterine clear cell carcinoma
Mod Pathol
(2004)
Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma
Gynecol Oncol
(2004)
JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin- embedded tissue
J Mol Diagn
(2005)
Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/ JJAZ1 gene fusion in t(7;17)
Cancer Genet Cytogenet
(2003)
HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes
Lab Invest
(2000)
Identification of a BAC clone overlapping the t(6p12.3) breakpoint in the cell line ESS-1 derived from an endometrial stromal sarcoma
Cancer Genet Cytogenet
(2003)
Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization
Gynecol Oncol
(2005)
Allelic imbalances in endometrial stromal neoplasms: frequent genetic alterations in the nontumorous normal-appearing endometrial and myometrial tissues
Gynecol Oncol
(2004)
DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis
Mod Pathol
(2006)
Malignant mixed Mullerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases
Gynecol Oncol
(1998)
The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma
Gynecol Oncol
(1996)
Cancer-susceptibility genes. Gatekeepers and caretakers
Nature
(1997)
Two molecular pathways to transitional cell carcinoma of the bladder
Cancer Res
(1994)
Microsatellite instability: the mutator that mutates the other mutator
Nat Med
(1996)
Chromosomal translocations and sarcomas
Curr Opin Oncol
(2002)
MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas
J Cancer Res Clin Oncol
(1998)
A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses
Verh Dtsch Ges Pathol
(1997)
Molecular pathogenesis and prognostic factors in endometrial carcinoma
Apmis
(2002)
Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas
Mod Pathol
(1997)
Case-control study of endogenous steroid hormones and endometrial cancer
J Natl Cancer Inst
(1996)
Risk of endometrial cancer following estrogen replacement with and without progestins
J Natl Cancer Inst
(1999)
Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern
Cancer
(1996)
Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers
J Natl Cancer Inst
(2000)
Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma
Cancer Res
(1994)
PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma
Cancer Res
(1998)
Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry
J Pathol
(2000)
Cited by (0)
Copyright © 2007 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.